|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 28.04 USD | +0.47% |
|
-4.53% | +97.60% |
| 09-28 | Raymond James Downgrades Acadia Healthcare to Outperform From Strong Buy | MT |
| 09-14 | BofA Adjusts Price Target on Acadia Healthcare to $17 From $14.50 | MT |
| Market Cap | 2.61B 2.3B 2.18B 1.98B 3.71B 250B 3.74B 26.15B 10.08B 128B 9.8B 9.59B 412B | P/E 2026 * |
32.2x | P/E 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.83B 4.26B 4.03B 3.66B 6.86B 464B 6.93B 48.4B 18.66B 237B 18.15B 17.75B 762B | EV / Sales 2026 * |
1.41x | EV / Sales 2027 * | 1.31x |
| Free-Float |
98.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ACHC | Delayed | |
CBOE
| ACHC | Real-time | |
|
Mexican S.E.
| ACHC * | End-of-day quote | |
|
Xetra
| 7RA | Delayed | |
|
Deutsche Boerse AG
| 7RA | Delayed | |
|
Börse Stuttgart
| 7RA | Delayed | |
|
Boerse Muenchen
| 7RA | Real-time | |
|
Borsa Italiana
| 1ACHC | End-of-day quote |
Last Transcript: Acadia Healthcare Company, Inc.
| 1 day | +0.47% | ||
| 1 week | -4.53% | ||
| Current month | +1.74% | ||
| 1 month | -1.79% | ||
| 3 months | +1.26% | ||
| 6 months | +22.39% | ||
| Current year | +97.60% |
| 1 week | 27 |  | 28.65 |
| 1 month | 26.85 | | 29.8 |
| Current year | 11.43 | | 35.83 |
| 1 year | 11.43 | | 35.83 |
| 3 years | 11.43 | | 87.77 |
| 5 years | 11.43 | | 89.85 |
| 10 years | 11.09 | | 89.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Debra Osteen
CEO | Chief Executive Officer | 70 | 2018-12-15 |
David Duckworth
DFI | Director of Finance/CFO | 46 | 2026-04-30 |
Laura Groschen
CTO | Chief Tech/Sci/R&D Officer | 60 | 2022-01-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Reeve Waud
CHM | Chairman | 62 | 2018-12-15 |
William Grieco
BRD | Director/Board Member | 72 | 2011-03-31 |
E. Bissell
BRD | Director/Board Member | 66 | 2013-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/26/26 | Tax | General Counsel | -1,770 | 0.0019% | ||
| 5/6/26 | Free | Director | 6,331 | 0.0069% | ||
| 5/6/26 | Free | Director | 11,831 | 0.0128% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -4.53% | +14.26% | -60.12% | 2.61B | |
| -0.85% | 0.00% | +15.26% | +24.75% | 111B | |
| -0.22% | -1.48% | +2.54% | +75.47% | 93.45B | |
| +1.56% | -3.01% | -4.88% | +50.03% | 28.21B | |
| -2.38% | -1.19% | +22.84% | +90.36% | 25.6B | |
| +2.83% | +0.31% | -16.41% | -6.11% | 20.45B | |
| -0.13% | -1.70% | +28.03% | +290.95% | 20.74B | |
| +0.08% | -2.37% | -11.35% | +47.58% | 15.61B | |
| +0.50% | -0.63% | -11.89% | -2.94% | 11.77B | |
| -1.62% | -4.64% | +34.15% | +85.33% | 11.17B | |
| Average | +0.28% | -2.41% | +7.26% | +59.53% | 34.1B | |
| Weighted average by Cap. | +0.55% | -1.48% | +8.01% | +61.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.43B 3.03B 2.86B 2.6B 4.87B 329B 4.91B 34.34B 13.23B 168B 12.87B 12.59B 541B | 3.63B 3.2B 3.03B 2.75B 5.15B 348B 5.2B 36.34B 14.01B 178B 13.62B 13.33B 572B |
| Net income | 87.55M 77.27M 73.11M 66.3M 124M 8.4B 126M 877M 338M 4.29B 329M 322M 13.81B | 169M 149M 141M 128M 240M 16.21B 242M 1.69B 652M 8.28B 634M 621M 26.64B |
| Net Debt | 2.22B 1.96B 1.86B 1.68B 3.15B 213B 3.19B 22.25B 8.58B 109B 8.34B 8.16B 350B | 2.15B 1.9B 1.79B 1.63B 3.05B 206B 3.08B 21.53B 8.3B 105B 8.07B 7.89B 339B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$28.04 | +0.47% | 920,843 |
| 26-09-28 | US$27.91 | -0.64% | 1,120,912 |
| 26-09-25 | US$28.09 | +1.04% | 1,150,321 |
| 26-09-24 | US$27.80 | -2.49% | 2,178,727 |
| 26-09-23 | US$28.51 | -2.93% | 2,464,969 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACHC Stock
Select your edition
All financial news and data tailored to specific country editions
